The Effect of Cardiac Rehabilitation on Ferroptosis in Patients With Coronary Artery Disease
Recruiting
N/A
Interventional Study
Coronary Artery Disease (CAD)
Cardiac Rehab
Ferroptosis
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
Healthy Volunteers Welcome
You do not need to have the condition being studied to take part.
At a Glance
- Age
- 18 – 75
- Sex
- Any
- Study type
- Interventional
- Purpose
- Treatment
- Participants needed
- 90 (estimated)
- Sponsor
- TC Erciyes University · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
Coronary artery disease (CAD) remains a major global health concern and is the leading cause of cardiovascular mortality worldwide. Cardiac rehabilitation (CR) is a comprehensive, evidence-based intervention that integrates exercise training with optimal medical management and has been shown to improve clinical outcomes in patients with CAD. The primary objective of this study is to investigate th…
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
Patients With Coronary Artery Disease (CAD):
* Age between 18 and 75 years.
* Diagnosis of coronary artery disease within the previous 3 months.
* Eligible to participate in a cardiac rehabilitation program or voluntarily decline participation in the cardiac rehabilitation prog…
Contacts
No contact information available.